The clinical development of the glass‐ionomer cement. III. The erosion lesion*

Abstract
Abstract— A clinical trial of the glass‐ionomer cement, ASPA IV, as a restorative material for erosion lesions is reported. The failure rate, in a three‐year trial, was nine per cent; most failures occurring within the first few months after placement.

This publication has 0 references indexed in Scilit: